Navigation Links
Telik Announces Financial Results for 2008 Third Quarter
Date:11/5/2008

PALO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) reported a net loss of $8.0 million, or $0.15 per share, for the third quarter ended September 30, 2008, compared with a net loss of $11.6 million, or $0.22 per share, for the comparable period in 2007. The $8.0 million net loss includes a $670,000 impairment charge related to corporate and municipal notes investments with an auction reset feature, or auction rate securities, which is reflected in interest and other income (expense). As of September 30, 2008, Telik has recognized impairment charges totaling $6.2 million against $18.7 million of par value auction rate securities. At September 30, 2008, Telik had $64.6 million in cash, cash equivalents and investments including restricted investments, compared to $72.4 million at June 30, 2008 and $93.2 million at December 31, 2007.

All of Telik's auction rate securities were sold to the Company by UBS AG ("UBS"). In October 2008, UBS offered Telik the right to sell at par value all of its auction-rate securities to UBS during a two-year period beginning June 30, 2010. The offer to accept this right is non-transferable and expires on November 14, 2008.

For the quarter ended September 30, 2008, total operating costs and expenses were $7.8 million, compared with $13.0 million in the 2007 third quarter and $11.0 million in the second quarter of 2008. Operating expenses in the 2008 third quarter included stock-based compensation expense of approximately $1.6 million. Operating expenses were approximately 40% lower in the third quarter of 2008 compared with the same period in 2007, primarily as a result of reduced clinical trial and related expenses as well as lower headcount and administrative expenses.
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
2. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
3. Telik Announces Receipt of Nasdaq Notice
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. ReceptorBio Announces Diabetes License Agreement With Telik
6. Telik Announces Financial Results For 2008 Second Quarter
7. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
8. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
9. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
10. Telik Announces First Quarter 2008 Financial Results
11. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Applied Rigaku Technologies, ... that details the measurement of sulfur in ultra-low sulfur ... high resolution benchtop EDXRF analyzer . The analysis detailed ... method ISO 13032. This International Standard specifies an ... determination of sulfur content in automotive gasoline. , Regulations ...
(Date:6/18/2013)... Santa Clara, CA (PRWEB) June 18, 2013 ... compared to standard size SEMs but have limited performance ... and lower resolution. Full size SEMs would normally provide ... require more knowledge to operate and have a higher ... SEMs address the gap between these two types ...
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... Wilmington, DE (PRWEB) June 18, 2013 ... teachers to the 11th annual DuPont National AgriScience Teachers ... Chesapeake Farms in Chestertown, Md. , ... sponsored by DuPont and is a special project of ... National Association of Agricultural Educators (NAAE) . The ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3ExakTime Introduces AccountLinx Plus 2DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3
... 20 CV Therapeutics, Inc. (Nasdaq: CVTX ... thoroughly reviewed and rejected the previously announced unsolicited proposal ... a price of $16.00 per share. After careful ... legal advisors, the CV Therapeutics board concluded that the ...
... AMSTERDAM, February 20 Elsevier announced today,that ... abstract and,citation (A&C) database, was chosen by ... in Research for Australia (ERA) initiative. , ... will assess research quality within Australia,s higher,education ...
... DUBLIN, February 20 Shire plc,(LSE: SHP, NASDAQ: ... it has signed an agreement with UCB to acquire ... (excluding the,USA, Canada and Barbados) used for the treatment ... EQUASYM XL is approved and marketed in 10 ...
Cached Biology Technology:CV Therapeutics' Board of Directors Rejects Astellas Unsolicited Proposal 2CV Therapeutics' Board of Directors Rejects Astellas Unsolicited Proposal 3CV Therapeutics' Board of Directors Rejects Astellas Unsolicited Proposal 4The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape 2The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape 3Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL 2Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL 3Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL 4
(Date:6/19/2013)... further proof that the divergence of humans from chimpanzees ... profoundly influenced by mutations to DNA sequences that play ... study, published June 9 in Nature Genetics , ... genes must play an important role in evolution since ... the proteins produced by genes. Indeed, human and chimpanzee ...
(Date:6/18/2013)... University of Calgary,s Faculty of Medicine have discovered a ... harmful bacteria. Platelets, a component of blood typically associated ... bacteria, and upon detection, seal it off from the ... in Nature Immunology this week, provide the ... "The science community has known that platelets do participate ...
(Date:6/18/2013)... Laboratory of Molecular Biology, has been honored as ... Award. Torrent is being recognized for his outstanding ... predict antimicrobial regions in proteins. Luis Rivas, Centro ... this algorithm to interrogate full genomes in order ... appealing results." , Torrent obtained his Ph.D. ...
Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Immunity mechanism discovered 2The American Society for Microbiology honors Marc Torrent 2
... engine that could, the University of Nevada, Reno experiment ... along, dwarfed by the million-gallon tanks, pipes and pumps ... the plant,s electrical power could be supplied on-site by ... very pleased with the results of the demonstration testing ...
... from discoveries of ancient tools and artifacts may need ... finding suggested by a new study that for the ... and goats trampling artifacts into mud. In seeking ... new study documented how animal trampling in a water-saturated ...
... BOSTONDana-Farber Cancer Institute,s Belfer Institute of Applied ... and NYSE: SNY) announced today that they have ... to identify and validate novel oncology targets ... novel therapeutics agents directed to such targets and ...
Cached Biology News:University of Nevada, Reno, demonstrates successful sludge-to-power research 2University of Nevada, Reno, demonstrates successful sludge-to-power research 3Taking a new look at old digs: Trampling animals may alter Stone Age sites 2Taking a new look at old digs: Trampling animals may alter Stone Age sites 3Dana-Farber and sanofi-aventis establish cancer research alliance 2
AK6 Antibody...
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Goat anti-mouse gamma chain-HRP...
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Biology Products: